ADDICTIVE BEHAVIORS is a prestigious journal published by PERGAMON-ELSEVIER SCIENCE LTD, specializing in the critical examination and exploration of addiction-related issues across diverse fields including Clinical Psychology, Psychiatry and Mental Health, and Toxicology. With a robust history dating back to 1975 and convergence extending to 2024, the journal is esteemed for its rigorous peer-reviewed research that contributes significantly to understanding addiction phenomena. Ranked in the Q1 category for its focus areas, it stands out within the academic community, evidenced by its impressive Scopus rankings—25th in Clinical Psychology and 14th in Toxicology—placing it in the top tier of its disciplines. This journal offers valuable insights into addiction behaviors, treatment methodologies, and public health implications, making it an essential resource for researchers, practitioners, and students seeking to advance their knowledge and impact the field. Although not Open Access, it provides vital access options for institutions and individuals invested in addiction studies.

JOURNAL OF DRUG EDUCATION, published by SAGE Publications Inc, serves as a vital platform for disseminating research and scholarly articles in the fields of health education, medicine, and mental health, focusing on drug-related issues. With its history dating back to 1972 and an ongoing publication cycle through 2024, the journal aims to enrich professional practice and inform policy-making through rigorous research. Although it does not currently operate under an Open Access model, the journal holds respectable rankings, finding itself in the third quartile across multiple categories including Health (Social Science), Medicine (Miscellaneous), Psychiatry and Mental Health, and Public Health, Environmental and Occupational Health, as per the 2023 metrics. This evaluation signifies its contribution to the discourse surrounding drug education and public health albeit within a competitive landscape. Scholars, researchers, and practitioners in the field are encouraged to engage with and contribute to this important dialogue addressing drug-related challenges in contemporary society.

Journal of the International Association of Providers of AIDS Care, published by SAGE PUBLICATIONS INC, is a distinguished open-access journal dedicated to the field of HIV/AIDS care and research. Since its inception in 2002, the journal has provided an essential platform for the dissemination of high-quality, peer-reviewed scholarly articles that advance knowledge in exciting areas such as dermatology, immunology, and infectious diseases. With an impact factor that highlights its role in shaping ongoing discourse, the journal boasts a strong reputation, reflected in its Q1 status in Dermatology and consistent ranking in the top tiers for immunology and infectious diseases in the Scopus Ranks. This commitment to excellence ensures that researchers, healthcare professionals, and students have access to the latest advancements and best practices in HIV/AIDS prevention and care. As a pivotal resource in the global health landscape, the journal stands at the forefront of efforts to combat the challenges presented by this ongoing epidemic.

SEXUALLY TRANSMITTED INFECTIONS is a premier academic journal published by the BMJ PUBLISHING GROUP, dedicated to advancing research in the crucial fields of dermatology and infectious diseases. With a solid impact factor that reflects its quality, this journal occupies a prestigious Q1 category in both dermatology and infectious diseases, indicating its influence and reputation among peers. This journal serves as a vital platform for disseminating research findings, clinical studies, and reviews relevant to sexually transmitted infections, aiming to improve treatment outcomes and public health. Researchers, healthcare professionals, and students will find this journal invaluable for staying informed on the latest developments, trends, and challenges in the field. Available in both print and online formats, SEXUALLY TRANSMITTED INFECTIONS is committed to fostering a deeper understanding and awareness of sexually transmitted diseases globally.

Journal of HIV-AIDS & Social Services is a pivotal academic platform committed to advancing the understanding and management of HIV-AIDS through the lens of social services. Published by Routledge Journals, Taylor & Francis Ltd, this journal spans significant years from 2002 to 2024, making it a key resource for the latest research and practices in the intersecting fields of health and social sciences. With an ISSN of 1538-1501 and an E-ISSN of 1538-151X, the journal holds a respectable position within the academic community, marked by its categorization in the Q3 quartile of both Health (Social Science) and Infectious Diseases as of 2023. The journal strives to provide a forum for innovative research addressing the complexities of HIV-AIDS, incorporating perspectives from various stakeholders, including healthcare providers, policymakers, and community organizations. Although it currently does not offer open access options, its indexed presence and dedicated readership ensure the dissemination of vital knowledge in a field that is more critical than ever. For researchers, professionals, and students dedicated to combating HIV-AIDS, this journal serves not just as a publication, but as a catalyst for change in global health initiatives.

AIDS CARE - Psychological and Socio-Medical Aspects of AIDS/HIV, published by Routledge Journals, Taylor & Francis Ltd, serves as a vital interdisciplinary platform for researchers, clinicians, and policymakers exploring the complex psychological and socio-medical dimensions of HIV/AIDS. With an ISSN of 0954-0121 and an E-ISSN of 1360-0451, this esteemed journal has been disseminating significant research since 1989 and continues to uphold a commendable reputation in the field, achieving a Q2 ranking in esteemed categories such as Health (Social Science), Public Health, and Social Psychology as per 2023 metrics. Its commitment to enhancing understanding of HIV/AIDS through quantitative and qualitative research makes it essential for stakeholders engaged in health strategies and mental health interventions. While currently not offering open access, the journal provides access to a wealth of authoritative articles that contribute meaningfully to the ongoing discourse surrounding HIV/AIDS and its socio-psychological ramifications. Researchers and students aiming to deepen their knowledge and intervention strategies will find this journal an invaluable resource.

JOURNAL OF PSYCHOACTIVE DRUGS, published by Routledge Journals, Taylor & Francis Ltd, stands as a leading resource in the fields of psychology and medicine, focusing on the intersection of psychoactive substances and their impact on human behavior. With an ISSN of 0279-1072 and E-ISSN 2159-9777, this esteemed journal has been a pivotal platform for rigorous research since its inception in 1967, contributing to the understanding of drug use, its societal implications, and therapeutic potentials. It currently holds a Q2 ranking in both the miscellaneous categories of Medicine and Psychology for 2023, reflecting its significant standing within academic circles. Moreover, its Scopus rankings place it at the 49th percentile in General Psychology and 101st in Medicine, underscoring its relevance in contemporary research. Although it is not available via Open Access, the journal maintains a commitment to advancing knowledge through its annual publications until 2024. JOURNAL OF PSYCHOACTIVE DRUGS is essential for researchers, professionals, and students seeking to explore the complexities of psychoactive substances and their effects in various contexts.

Annals of Clinical Psychiatry, published by QUADRANT HEALTHCOM INC, is a leading journal in the fields of Medicine and Psychiatry & Mental Health. With its longstanding commitment to advancing clinical knowledge since 1989, this esteemed journal contributes invaluable insights into current psychiatric practices and mental health research. The journal is recognized in the Scopus ranking with a position in the 34th percentile, reflective of its focused scope and substantial academic contributions. While access to the journal is tailored for professionals and researchers, the absence of Open Access highlights the journal's dedication to maintaining quality and rigorous peer-reviewed standards. As part of the Q3 quartile for both Medicine and Psychiatry categories in 2023, Annals of Clinical Psychiatry serves as an essential resource for those dedicated to improving mental health outcomes, making it a vital platform for practitioners, researchers, and students alike. Situated in Parsippany, New Jersey, the journal remains a pivotal entity that fosters scholarly dialogue and exploration in clinical psychiatry.

HIV Medicine is a prestigious journal published by Wiley that stands at the forefront of research in the fields of health policy, infectious diseases, and pharmacology, with a commendable impact factor reflected in its Q1 rankings for 2023. Established in 1999 and set to converge its expertise through 2024, this journal plays a critical role in advancing the understanding and treatment of HIV and related health challenges. It is esteemed for its rigorous peer-review process and its contributions to both clinical and policy-oriented discussions surrounding HIV medicine. With a broad international readership, it serves as a vital resource for researchers, healthcare professionals, and students committed to fighting the global HIV epidemic. Although not open access, its vital insights are indispensable for anyone involved in infectious disease research and healthcare policy. Articles published in HIV Medicine shape global health strategies and influence the future of HIV research, making it a must-read for those dedicated to this crucial field.

INTERNATIONAL JOURNAL OF STD & AIDS is a prominent publication dedicated to advancing the understanding and treatment of sexually transmitted diseases and HIV/AIDS. Published by SAGE Publications Ltd, this esteemed journal has been contributing to the medical community since 1990, with a convergence of studies spanning to 2024. With its ISSN 0956-4624 and E-ISSN 1758-1052, the journal is recognized for its rigorous peer-reviewed research and has successfully positioned itself in the second quartile (Q2) of Dermatology and Public Health, alongside notable rankings in Infectious Diseases and Pharmacology. Currently based in the United Kingdom, this journal serves as a crucial resource for researchers, healthcare professionals, and students, providing a platform for innovative studies and critical reviews that address global health challenges. Although it does not offer Open Access, the journal continues to maintain its reputation as a vital reference point for those invested in the fields of dermatology, public health, and infectious diseases.